Is TAS-118 Plus Oxaliplatin a New Standard First-Line Therapy for Advanced Gastric Cancer in Asians? Is TAS-118 Plus Oxaliplatin a New Standard First-Line Therapy for Advanced Gastric Cancer in Asians?

TAS-118 plus oxaliplatin was more effective than S-1 plus cisplatin in a phase 3 trial and could be considered a new first-line treatment for advanced gastric cancer in Asian patients, researchers suggest.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news